Bibliografía
1. 1. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil. 2013;21(1):16-21.
2. 2. Blanco FJ, Silva-Díaz M, Quevedo Vila V, Seoane-Mato D, Pérez Ruiz F, Juan-Mas A, et al; en representación del Grupo de Trabajo del Proyecto EPISER2016. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study. Reumatol Clin (Engl Ed). 2020:S1699-258X(20)30023-1. DOI: 10.1016/j.reuma.2020.01.008.
3. 3. Moskowitz RW. The burden of osteoarthritis: clinical and quality- of-life issues. Am J Manag Care. 2009;15(8 Suppl):S223-S229.
4. 4. Puig-Junoy J, Ruiz Zamora A. Socio-economic costs of osteo- arthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum. 2015;44(5):531-41.
5. 5. Herrero-Beaumont G, Roman-Blas JA, Bruyère O, Cooper C, Kanis J, Maggi S, et al. Clinical settings in knee osteoarthritis: pathophysiology guides treatment. Maturitas. 2017; 96:54-7.
6. 6. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137-62.
7. 7. Center for Disease Control and Prevention [Internet]. Fact Sheet; 2021. Disponible en:https://www.cdc.gov/arthritis/basics/ osteoarthritis.htm. Accessed 24 May 2021
8. 8. Bowman S, Awad ME, Hamrick MW, Hunter M, Fulzele S. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Trans Med. 2018;7(1):6.
9. 9. Oe M, Tashiro T, Yoshida H, Nishiyama H, Masuda Y, Maruyama K, et al. Oral hyaluronan relieves knee pain: a review. Nutr J. 2015; 15:11.
10. 10. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthri- tis Res Ther. 2003;5(2):54-67.
11. 11. Cooper C, Rannou F, Richette P, Bruyère O, Al-Daghri N, Altman RD, et al. Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice. Arthritis Care Res (Hoboken). 2017;69(9):1287-96.
12. 12. Priano F. Early Efficacy of Intra-Articular HYADD® 4 (Hymovis®) Injections for Symptomatic Knee Osteoarthritis. Joints. 2017;5(2):79-84.
13. 13. Nguyen C, Rannou F. The safety of intra-articular injections for the treatment of knee osteoarthritis: a critical narrative review. Expert Opin Drug Saf. 2017;16(8):897-902.
14. 14. Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil. 2003;84(2):1224-6.
15. 15. Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R, et al. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoar- thritis. Orthopedics. 2013;36(12):e1501-e1508.
16. 16. Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, et al. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a Randomized Controlled Study. Am J Sports Med. 2016;44(3):664-71.
17. 17. Han Y, Huang H, Pan J, Lin J, Zeng L, Liang G, et al. Meta-analysis. comparing platelet-rich plasma vs hyaluronic acid injection in patients with knee osteoarthritis. Pain Med. 2019;20(7):1418-29.
18. 18. Di Martino A, Di Matteo B, Papio T, Tentoni F, Selleri F, Cenacchi A, et al. Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med. 2019;47(2):347-54.
19. 19. Zhao J, Huang H, Liang G, Zeng LF, Yang W, Liu J. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020;21(1):224.
20. 20. Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci Rep. 2021;11(1):3971.
21. 21. Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, et al. Platelet-rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-Infammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352(1):146-56.
22. 22. Torres LM, García-Palacios M, Benítez D, Eizaga R, López-López J, Sánchez de las Matas R, et al. Tratamiento con la administración intradiscal de plasma rico en plaquetas para dolor crónico discogénico cervical y lumbar. MPJ. 2021;1. DOI: 1020986/mpj20211001/2021.
23. 23. Raeissadat SA, Rayegani SM, Babaee M, Ghorbani E. The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis. Pain Res Treat. 2013;2013:165967.
24. 24. Cubukçu D, Ardiç F, Karabulut N, Topuz O. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol. 2005;24(4):336-41.
25. 25. Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil. 2003;84(8):1224-6.
26. 26. Piccirilli E, Oliva F, Murè MA, Mahmoud A, Foti C, Tarantino U, et al. Viscosupplementation with intra-articular hyaluronic acid for hip disorders. A systematic review and meta-analysis. Muscles Ligaments Tendons J. 2016;6(3):293-9.
27. 27. Chang KV, Hsiao MY, Chen WS, Wang TG, Chien KL. Effectiveness of intra-articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2013;94(5):951-60.